Lazarova M, Tsvetanova E, Georgieva A, Stefanova M, Uzunova D, Denev P
Int J Mol Sci. 2024; 25(3).
PMID: 38339117
PMC: 10855470.
DOI: 10.3390/ijms25031840.
Chhimpa N, Singh N, Puri N, Kayath H
J Alzheimers Dis. 2023; 94(s1):S453-S472.
PMID: 37393492
PMC: 10473122.
DOI: 10.3233/JAD-220514.
Zhang X, Alshakhshir N, Zhao L
Front Neurosci. 2021; 15:662242.
PMID: 33994936
PMC: 8113697.
DOI: 10.3389/fnins.2021.662242.
Pope C, Brimijoin S
Biochem Pharmacol. 2018; 153:205-216.
PMID: 29409903
PMC: 5959757.
DOI: 10.1016/j.bcp.2018.01.044.
Smith G, Barrett F, Joo J, Nassery N, Savonenko A, Sodums D
Neurobiol Dis. 2017; 105:33-41.
PMID: 28511918
PMC: 5663212.
DOI: 10.1016/j.nbd.2017.05.007.
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
Rajmohan R, Reddy P
J Alzheimers Dis. 2016; 57(4):975-999.
PMID: 27567878
PMC: 5793225.
DOI: 10.3233/JAD-160612.
Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease.
Cunnane S, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M
Front Mol Neurosci. 2016; 9:53.
PMID: 27458340
PMC: 4937039.
DOI: 10.3389/fnmol.2016.00053.
Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.
Ahmed T, Zahid S, Mahboob A, Farhat S
Curr Neuropharmacol. 2016; 15(4):480-494.
PMID: 27012953
PMC: 5543671.
DOI: 10.2174/1570159X14666160325121145.
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.
Hirao K, Pontone G, Smith G
Neurosci Biobehav Rev. 2014; 49:157-70.
PMID: 25446948
PMC: 4806385.
DOI: 10.1016/j.neubiorev.2014.11.010.
The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.
Shah K, Desilva S, Abbruscato T
Int J Mol Sci. 2012; 13(10):12629-55.
PMID: 23202918
PMC: 3497292.
DOI: 10.3390/ijms131012629.
Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.
Swerdlow R
Antioxid Redox Signal. 2011; 16(12):1434-55.
PMID: 21902597
PMC: 3329949.
DOI: 10.1089/ars.2011.4149.
Brain fuel metabolism, aging, and Alzheimer's disease.
Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S
Nutrition. 2010; 27(1):3-20.
PMID: 21035308
PMC: 3478067.
DOI: 10.1016/j.nut.2010.07.021.
Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies.
Maloney M, Bamburg J
Mol Neurobiol. 2007; 35(1):21-44.
PMID: 17519504
DOI: 10.1007/BF02700622.
Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.
Lovell M, Xiong S, Markesbery W, Lynn B
Neurochem Res. 2005; 30(1):113-22.
PMID: 15756939
DOI: 10.1007/s11064-004-9692-5.
Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.
Forstl H, Fischer P
Eur Arch Psychiatry Clin Neurosci. 1994; 244(5):252-60.
PMID: 7893771
DOI: 10.1007/BF02190378.
Pharmacological aspects of gerontological brain research.
Meier-Ruge W
Experientia. 1981; 37(10):1053-5.
PMID: 7308386
DOI: 10.1007/BF02085005.
Organic mental impairment in the elderly. Implications for research, education and the provision of services. A report of the Royal College of Physicians by the College Committee on Geriatrics.
J R Coll Physicians Lond. 1981; 15(3):141-67.
PMID: 7252889
PMC: 5377624.
The noradrenergic system in Alzheimer and multi-infarct dementias.
Mann D, YATES P, Hawkes J
J Neurol Neurosurg Psychiatry. 1982; 45(2):113-9.
PMID: 7069423
PMC: 1083037.
DOI: 10.1136/jnnp.45.2.113.
Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
Sorbi S, Antuono P, Amaducci L
Ital J Neurol Sci. 1980; 1(2):75-83.
PMID: 7040296
DOI: 10.1007/BF02336848.
Non-surgical management of peripheral vascular disease: a review.
Clyne C
Br Med J. 1980; 281(6243):794-7.
PMID: 7000278
PMC: 1714011.
DOI: 10.1136/bmj.281.6243.794.